<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04177446</url>
  </required_header>
  <id_info>
    <org_study_id>HS-2028</org_study_id>
    <nct_id>NCT04177446</nct_id>
  </id_info>
  <brief_title>A Study About Nutritional Support of Enhanced Protein in Critical Patients</brief_title>
  <official_title>A Multicenter Randomized Controlled Clinical Study With WeiYuan Tai (a Nutritional Supplement) on Nutritional Support of Enhanced Protein in Severe Patients(Tai Shan)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking Union Medical College Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Yabao Pharmaceutical Group</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second Affiliated Hospital of Dalian Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First Affiliated Hospital of Zhengzhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking Union Medical College Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized controlled trial. 180 patients with critical illness will be
      included and randomly divided into two groups. In the control group, patients will be fed
      with basic energy; and in the experiment group, the patients will be given extra protein
      intake except the basic energy intake. The intervention duration will last 6 days. The
      primary outcomes of this study are urea nitrogen of 24h and prealbumin(PA). And other
      outcomes include nutritional status, safety indicators and clinical indicators.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Critical illness patients are commonly in the risk of malnutrition, because of various
      factors. And nutritional supplement, particularly the supplement of protein, can decrease the
      nitrogen balance, improve the nutritional status, accelerate the speed of healing and
      decrease the mortality rate. This is a multi center prospective randomized controlled trial.
      180 patients with critical illness will be included and randomly divided into two groups. In
      the control group, patients will be fed with basic energy; and in the experiment group, the
      patients will be given extra protein intake except the basic energy intake. The intervention
      duration will last 6 days. The primary outcomes of this study are urea nitrogen of 24h and
      prealbumin(PA). And other outcomes include nutritional status(total protein, albumin, grip
      and calf circumference), safety indicators(liver function, kidney function, tolerance, etc.)
      and clinical indicators(overall complication rate, length of hospital stay and cost).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 25, 2019</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>urea nitrogen of 24h</measure>
    <time_frame>day6</time_frame>
    <description>the total amount of urea nitrogen in 24 hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>prealbumin(PA)</measure>
    <time_frame>day6</time_frame>
    <description>the level of prealbumin in blood</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>total protein</measure>
    <time_frame>day6</time_frame>
    <description>the total protein level in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>albumin</measure>
    <time_frame>day6</time_frame>
    <description>the level of albumin in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>calf circumference</measure>
    <time_frame>change from baseline calf circumference at 6 days</time_frame>
    <description>the perimeter of calf</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>grip</measure>
    <time_frame>change from baseline grip at 6 days</time_frame>
    <description>the strength(force measured kilograms) of the right hand measured by a hand-held dynamometer (if the right hand is not impossible, the left is ok )</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall complication rate</measure>
    <time_frame>from the day receiving enteral nutrition to day6</time_frame>
    <description>the over complication rate after receiving enteral nutrition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay</measure>
    <time_frame>from date of admission in the hospital until the date of discharge, up to 1 year</time_frame>
    <description>the overall time stay in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost in hospital</measure>
    <time_frame>from date of admission in the hospital until the date of discharge, up to 1 year</time_frame>
    <description>all the money paid in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>liver function</measure>
    <time_frame>day6</time_frame>
    <description>the level of AST/ALT in blood</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>renal function</measure>
    <time_frame>day6</time_frame>
    <description>the level of creatinine in blood</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will be given basic energy intake according to their weight, and will be extra maltodextrin as the placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be given basic energy intake according to their weight, and will be extra protein intake</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>a production consist of various oligopeptides and the whey protein</intervention_name>
    <description>patients will be given extra protein intake except the basic energy intake</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>basic energy intake</intervention_name>
    <description>supplement as basic energy intake</description>
    <arm_group_label>control group</arm_group_label>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>maltodextrin</intervention_name>
    <description>used as placebo in the control group</description>
    <arm_group_label>control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. diagnosed as critical illness, stayed in ICU;

          2. score of M-nutric ≥ 5;

          3. score of 3. APACHE Ⅱ &gt;12;

          4. anticipation of length of hospital stay &gt; 6 days;

          5. 18 ≤ age ≤ 45;

          6. pattens volunteer to attend this study and sigh the inform consent form;

        Exclusion Criteria:

          1. liver function(AST/ALT) of blood test ≥ 2.5 ULN(upper limit of normal); renal function
             of blood test &gt; 1.6 ULN;

          2. the patients are used or are planned to use the Human Albumin solution within 3 days
             before receiving enteral nutrition;

          3. consume any natural food or something made by natural food;

          4. patients are used or are planned to use all-in-one solution or amino acid solution
             within 3 days before receiving enteral nutrition;

          5. anticipation of survival time is less than 5 days;

          6. have the contraindications of enteral nutrition;

          7. patients are allergic to material of the production;

          8. patients who are considered not suitable for this study by investigators;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Chen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking Union Medical College Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei Chen</last_name>
    <phone>+86(010)69154095</phone>
    <email>chenw@pumch.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhangping Yu</last_name>
    <phone>+86(010)69154095</phone>
    <email>yuzhangping1993@163.com</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019 Feb;38(1):48-79. doi: 10.1016/j.clnu.2018.08.037. Epub 2018 Sep 29.</citation>
    <PMID>30348463</PMID>
  </results_reference>
  <results_reference>
    <citation>Arabi YM, Al-Dorzi HM, Mehta S, Tamim HM, Haddad SH, Jones G, McIntyre L, Solaiman O, Sakkijha MH, Sadat M, Afesh L, Kumar A, Bagshaw SM, Aldawood AS; PermiT Trial Group. Association of protein intake with the outcomes of critically ill patients: a post hoc analysis of the PermiT trial. Am J Clin Nutr. 2018 Nov 1;108(5):988-996. doi: 10.1093/ajcn/nqy189.</citation>
    <PMID>30475959</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 11, 2019</study_first_submitted>
  <study_first_submitted_qc>November 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking Union Medical College Hospital</investigator_affiliation>
    <investigator_full_name>Wei Chen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>national support</keyword>
  <keyword>protein</keyword>
  <keyword>critical illness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The following data will be shared at the end of the study: demographic data, other baseline data of patients and date of outcomes collected at this research</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>The data is expected to be available after, December, 2020 and can be used forever</ipd_time_frame>
    <ipd_access_criteria>The information should be used for academic research, medical communication, etc., and is prohibited from being used for commercial gain.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

